FDA Approved: NARATRIPTAN — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for Naratriptan from Bionpharma Inc., indicating regulatory approval related to the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Naratriptan (Naratriptan)

Snippet

SUPPL AP for NARATRIPTAN (NARATRIPTAN)